Tag: Competition

Displaying 61 - 80 of 2739 results.

Pages

From: Gillis, Diana L.Sent: Wednesday, June 14, 2017 1:37 PMTo: [Redacted]; Walsh, Kathryn E.Cc: Jones, Robert L.; Shaffer, Kristin; Carson, Timothy; Whitehead, NoraSubject: RE: Bankruptcy reorganization - exchange of debt for equity[Redacted],
From: Walsh, Kathryn E.Sent: Thursday, June 08, 2017 10:55 AMTo: [Redacted]Cc: Gillis, Diana L.; Whitehead, NoraSubject: RE: HSR questionCorrect.From: [Redacted]Sent: Wednesday, June 07, 2017 9:36 AMTo: Walsh, Kathryn E.
From: Walsh, Kathryn E.Sent: Thursday, June 01, 2017 9:05 AMTo: [Redacted]; Berg, Karen E.Cc: [Redacted]; Gillis, Diana L.; Shaffer, KristinSubject: [Redacted][Redacted]:The issue here is the intent to acquire 100%. It is a long‐standing PNO position that when that is the intent, even...
The Federal Trade Commission will hold a workshop on November 8, 2017 entitled, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” Acting FTC Chairman Maureen K. Ohlhausen and U.S. Food and Drug Commissioner Dr. Scott Gottlieb will give the keynote addresses.
From: Gillis, Diana L.Sent: Wednesday, May 17, 2017 2:27 PMTo: [Redacted]Subject: RE: HSR Filing FeeCorrect.From: [Redacted]Sent: Wednesday, May 17, 2017 2:26 PMTo: Gillis, Diana L.Subject: HSR Filing FeeDiana,
From: Storm, EvanSent: Friday, May 12, 2017 2:15 PMTo: [Redacted]Cc: Shaffer, Kristin; Carson, Timothy; Whitehead, Nora; Gillis, Diana L.Subject: RE: Question regarding option exercise[Redacted]We agree that the shares would be valued at the “Market Price.”RegardsEvanFrom: [Redacted...
From: Gillis, Diana L.Sent: Thursday, May 11, 2017 11:00 AMTo: [Redacted] Walsh, Kathryn E.Subject: RE: MLPYes, that is the position.From: [Redacted]Sent: Thursday, May 11, 2017 10:07 AMTo: Walsh, Kathryn E.; Gillis, Diana L.Subject: MLPKate, Diana,
 From: Shaffer, KristinSent: Tuesday, May 09, 2017 3:49 PMTo: [Redacted] Walsh, Kathryn E.; Storm, Evan; Gillis, Diana L.; Whitehead, Nora;Berg, Karen E.; Carson, TimothySubject: RE: 801.30[Redacted],
From: Sheinberg, Samuel I.Sent: Tuesday, May 09, 2017 3:38 PMTo: [Redacted]Cc: Gillis, Diana L.; Walsh, Kathryn E.Subject: RE: Request for interpretation regarding waiting period for cash tender offer of MLP units (803.10(b))[Redacted]You are correct. The 15‐day waiting period for...
From: Gillis, Diana L.Sent: Thursday, May 04, 2017 2:57 PMTo: [Redacted]Cc: Whitehead, NoraSubject: RE: HSR earnout related guidance[Redacted]1) Unaudited financials, if relied upon by management, are required2) Otherwise, provide the most recent regularly prepared balance sheet, and...
Following a public comment period, the Federal Trade Commission has approved a final order in which the National Association of Animal Breeders agreed to refrain from adopting rules that unreasonably stifle competition among its members.
In order to reduce the burden associated with submitting detailed information for every document withheld on a claim of privilege, the Bureau has established an optional two-step privilege log process. Rather than submitting a complete privilege log for all withheld documents and...
Abbott Laboratories and Alere Inc. have agreed to a divestiture of two point-of-care medical device products line in order to settle Federal Trade Commission charges that Abbott’s proposed $8.3 billion acquisition of Alere will cause harm to competition.Abbott is a global healthcare company that...
Integra LifeSciences Holdings Corp. and Johnson & Johnson have agreed to a divestiture of five neurosurgical medical device product lines to settle Federal Trade Commission charges that Integra’s proposed $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively...
The Hatch-Waxman Act, passed by Congress more than 30 years ago, provides a regulatory and judicial framework to expedite generic entry into U.S. prescription drug markets. For many drugs, the Act has succeeded in lowering patent-related barriers to generic drug entry, thereby...
This paper reviews the economic literature on “conditional pricing practices.” Conditional pricing practices are pricing strategies in which a seller conditions its prices on factors such as volume, the set of products purchased, or the buyer’s share of purchases from the seller. This...

Pages